Sector: Health Care.Industry: Biotechnology
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VOR | Vor Biopharma | 3.76% |
Vor Biopharma Company Questions & Answers
Q
How do I buy Vor Biopharma (VOR) stock?
A
You can purchase shares of Vor Biopharma (NASDAQ: VOR) through any online brokerage.
Q
Who are Vor Biopharma's (VOR) main competitors?
A
Other companies in Vor Biopharma’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Amgen (NASDAQ:AMGN).
Q
What is the target price for Vor Biopharma?
A
The latest price target for Vor Biopharma (NASDAQ: VOR) was reported by B. Riley FBR on 2021-03-25. The analyst firm set a price target for 60.00 expecting VOR to rise to within 12 months (a possible 144.60% upside). 5 analyst firms have reported ratings in the last year.
Q
How much is Vor Biopharma (VOR) stock ?
A
The stock price for Vor Biopharma (NASDAQ: VOR) is $24.53 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Vor Biopharma (VOR) dividend?
A
There are no upcoming dividends for Vor Biopharma.
Q
When is Vor Biopharma (NASDAQ:VOR) reporting earnings?
A
Vor Biopharma’s Q1 earnings are confirmed after-market from now on June 8, 2021.
Q
When is the upcoming split for VOR?
A
There is no upcoming split for Vor Biopharma.